LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

LLY

759.75

-0.52%↓

JNJ

176.59

+0.08%↑

ABBV

220.03

+1.83%↑

UNH

341.1

+0.38%↑

AZN

77.6

-0.01%↓

Начало・Списък с акции・Pulmatrix Inc

Pulmatrix Inc

Затворен

4.89 -2.59

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.81

Максимум

5.03

Ключови измерители
By Trading Economics
Приходи	259K -1.5M
EPS	-0.42
Марж на печалбата	-60,266.667
Служители	2
EBITDA	260K -1.5M

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-804K 19M
Предишно отваряне	7.48
Предишно затваряне	4.89

Pulmatrix Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.09.2025 г., 17:03 ч. UTC

Значими двигатели на пазара

BrainsWay Shares Rise on FDA Clearance of Major Depressive Disorder Treatment

16.09.2025 г., 16:49 ч. UTC

Значими двигатели на пазара

Придобивния, сливания и поглъщания

GD Culture Shares Drop After Deal for Pallas Capital

16.09.2025 г., 16:11 ч. UTC

Значими двигатели на пазара

Corbus Shares Rise on FDA Fast-Track Designation for Cancer Drug

16.09.2025 г., 23:40 ч. UTC

Пазарно говорене

Nikkei May Decline as Yen Strengthens -- Market Talk

16.09.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

16.09.2025 г., 23:20 ч. UTC

Пазарно говорене

Restaurant Brands NZ Can Outperform When Cycle Turns -- Market Talk

16.09.2025 г., 21:10 ч. UTC

Придобивния, сливания и поглъщания

U.S. Investors, Trump Close In on TikTok Deal With China -- WSJ

16.09.2025 г., 20:51 ч. UTC

Пазарно говорене

U.S. Home Sales, New Home Listings Fall in August -- Market Talk

16.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

16.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

16.09.2025 г., 20:25 ч. UTC

Печалби

The AI Trade Has Stocks Near Highs Again. Some Tech Names Remain on the Sidelines -- Barrons.com

16.09.2025 г., 20:24 ч. UTC

Печалби

These Stocks Moved the Most Today: Oracle, Tesla, Alphabet, Dave & Buster's, Chipotle, and More -- Barrons.com

16.09.2025 г., 19:19 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Extend Winning Streak -- Market Talk

16.09.2025 г., 18:52 ч. UTC

Пазарно говорене

Oil Futures Advance on Russia Concerns, Weak Dollar -- Market Talk

16.09.2025 г., 18:44 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

16.09.2025 г., 18:44 ч. UTC

Пазарно говорене

EssilorLuxottica Well-Positioned in Growing Smart-Glasses Market -- Market Talk

16.09.2025 г., 18:40 ч. UTC

Придобивния, сливания и поглъщания

Details Emerge on U.S.-China TikTok Deal -- WSJ

16.09.2025 г., 18:38 ч. UTC

Пазарно говорене

Meta Seen With Long-Term Opportunity to Lead in Smart Glasses -- Market Talk

16.09.2025 г., 18:19 ч. UTC

Пазарно говорене

Gold Settles at New High Ahead of Fed Decision -- Market Talk

16.09.2025 г., 18:01 ч. UTC

Пазарно говорене

U.S. Dollar Weakness Supports Oil's Gains -- Market Talk

16.09.2025 г., 17:34 ч. UTC

Пазарно говорене

Any Question the Bank of Canada Will Cut Now Look to Have Vanished -- Market Talk

16.09.2025 г., 16:53 ч. UTC

Печалби

Software Companies Are Fighting Back With AI. The Stocks Are Still Hurting. -- Barrons.com

16.09.2025 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

16.09.2025 г., 16:15 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Commodities Roundup: Market Talk

16.09.2025 г., 16:09 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Energy Roundup: Market Talk

16.09.2025 г., 16:09 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Canada Industry Minister to Meet Mining CEOs on Merger -- Market Talk

16.09.2025 г., 15:35 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

16.09.2025 г., 15:35 ч. UTC

Пазарно говорене

Gold Soars Past $3,700 Ahead of Fed Decision -- Market Talk

16.09.2025 г., 15:22 ч. UTC

Пазарно говорене

More Investors Think Dollar is Overvalued in Latest BofA Survey -- Market Talk

16.09.2025 г., 15:21 ч. UTC

Пазарно говорене

Sterling Considered Most Overvalued in Nearly 10 Years -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pulmatrix Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Pulmatrix Inc през последните 3 месеца.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.